Cardiovascular Disease Doctors in St Louis, MO Accepting Medicare

7 Cardiovascular Disease doctors found. Showing 1 - 7

Dr. Bassam Nmi Al-joundi, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 10012 Kennerly Road, Suite #301, St Louis, MO 63128 Phone: 314-729-0088    Fax: 314-729-3963

Dr. Tammam Nmi Al-joundi, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 10012 Kennerly Road, Suite 301, St Louis, MO 63128 Phone: 314-729-0088    Fax: 314-729-3963

Bernard R Chaitman, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3660 Vista, St Louis, MO 63110 Phone: 314-725-4668    Fax: 314-268-5172

Dr. Liwa T Younis, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 10012 Kenerly Road, Suite 301, St Louis, MO 63128 Phone: 314-729-0088    Fax: 314-729-3974

Dr. Farhaan A Ahmad, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 10012 Kennerly Rd Suite 300, St Louis, MO 63128 Phone: 314-842-0602    Fax: 314-842-4372

Paul J Hauptman, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 3635 Vista Ave At Grand Blvd, St Louis, MO 63110 Phone: 314-577-8896    Fax: 314-268-5138

Deana Mikhalkova, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 660 South Euclid Ave, St Louis, MO 63110 Phone: 314-747-3000

News Archive

Virginia Mason and Vera Whole Health announce strategic collaboration

Virginia Mason and Vera Whole Health today announced a strategic collaboration that brings Virginia Mason's clinical best practices to Vera Whole Health's employer-funded primary care clinics.

Most COVID-19 patients died in the hospital, study finds

There have been over 280,000 deaths in the United States due to COVID-19, with the infectious nature of the disease preventing many patients from receiving end-of-life care at home.

Sihuan's Roxatidine passes Chinese SFDA on-site inspection

Sihuan Pharmaceutical Holdings Group Ltd., a leading pharmaceutical company with the largest cardio-cerebral vascular drug franchise in China's prescription market, announced that Roxatidine Acetate Hydrochloride for Injection, Sihuan Pharmaceutical's first-to-market generic drug, recently passed on-site inspection for drug registration conducted by the Chinese State Food and Drug Administration.

GHIT Fund invests in two innovative malaria eradication tools

The Global Health Innovative Technology Fund (GHIT Fund) announced today that it's investing US$1,383,785 in a pair of innovative malaria eradication tools—a vaccine that could block transmission of two species of the deadly disease and a rapid field test that can reveal a malaria infection in minutes.

Read more Medical News

› Verified 6 days ago